Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Protalix BioTherapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −3 vs. Q2 2022
- Shares held
- 3.55M
- +2.35M (+197.2%) vs. Q2 2022
- Total value
- $3.70M
- +$2.40M (+184.7%) vs. Q2 2022
- New holders
- 2
- 5 more added
- Sold out
- 5
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $31.0M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $12.4M |
| Q4 2023 | 66 | $18.1M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.52M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.71M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Highbridge Capital Management LLC | 2,413,487 | $2.51M | 0.04% | +2,413,487 | New |
| Meitav Dash Investments Ltd | 244,332 | $256.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 222,261 | $231.0K | 0.00% | +222,261 | New |
| Bridgeway Capital Management, LLC | 133,790 | $139.0K | 0.00% | −25,000−15.7% | Reduced |
| Renaissance Technologies LLC | 117,200 | $122.0K | 0.00% | +2,400+2.1% | Added |
| BlackRock Inc. | 98,763 | $103.0K | 0.00% | −2,790−2.7% | Reduced |
| Jane Street Group, LLC | 78,476 | $82.0K | 0.00% | −5,080−6.1% | Reduced |
| Citadel Advisors LLC | 58,557 | $61.0K | 0.00% | −1,358−2.3% | Reduced |
| Capital Performance Advisors LLP | 25,974 | $27.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 25,300 | $26.0K | 0.00% | −48,371−65.7% | Reduced |
| Davenport & Co LLC | 22,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| IHT Wealth Management, LLC | 22,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Aptus Capital Advisors, LLC | 13,957 | $15.0K | 0.00% | +1,539+12.4% | Added |
| Smith, Salley & Associates | 12,048 | $13.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 10,351 | $11.0K | 0.00% | −15,159−59.4% | Reduced |
| UBS Group AG | 11,118 | $11.0K | 0.00% | +10,998+9,165.0% | Added |
| Morgan Stanley | 8,217 | $9.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 6,000 | $6.30K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6,100 | $6.00K | 0.00% | 00.0% | Unchanged |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 5,761 | $6.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,027 | $3.00K | 0.00% | −477−13.6% | Reduced |
| Barclays PLC | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Ten Capital Wealth Advisors, LLC | 890 | $1.00K | 0.00% | +100+12.7% | Added |
| American Portfolios Advisors | 500 | $521 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 250 | $260 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 373 | $0 | 0.00% | +358+2,386.7% | Added |
| Spire Wealth Management | 0 | $0 | 0.00% | −148,800−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −28,816−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,223−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −395−100.0% | Sold out |